modafinil
Generic: modafinil
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
modafinil
Generic Name
modafinil
Labeler
aurobindo pharma limited
Dosage Form
TABLET
Routes
Active Ingredients
modafinil 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65862-601
Product ID
65862-601_f2c9beee-f9fc-44c5-bbbd-0d617c04ab0d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202566
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2012-09-27
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65862601
Hyphenated Format
65862-601
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
modafinil (source: ndc)
Generic Name
modafinil (source: ndc)
Application Number
ANDA202566 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (65862-601-01)
- 30 TABLET in 1 BOTTLE (65862-601-30)
- 90 TABLET in 1 BOTTLE (65862-601-90)
- 1000 TABLET in 1 BOTTLE (65862-601-99)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f2c9beee-f9fc-44c5-bbbd-0d617c04ab0d", "openfda": {"nui": ["N0000175729", "N0000175651", "N0000175769"], "unii": ["R3UK8X3U3D"], "rxcui": ["205324", "260218"], "spl_set_id": ["f51ca007-3955-4540-a88a-0ddae8d8e8ab"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]"], "pharm_class_epc": ["Sympathomimetic-like Agent [EPC]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (65862-601-01)", "package_ndc": "65862-601-01", "marketing_start_date": "20120927"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (65862-601-30)", "package_ndc": "65862-601-30", "marketing_start_date": "20120927"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (65862-601-90)", "package_ndc": "65862-601-90", "marketing_start_date": "20120927"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (65862-601-99)", "package_ndc": "65862-601-99", "marketing_start_date": "20120927"}], "brand_name": "Modafinil", "product_id": "65862-601_f2c9beee-f9fc-44c5-bbbd-0d617c04ab0d", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic-like Agent [EPC]"], "product_ndc": "65862-601", "dea_schedule": "CIV", "generic_name": "Modafinil", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Modafinil", "active_ingredients": [{"name": "MODAFINIL", "strength": "100 mg/1"}], "application_number": "ANDA202566", "marketing_category": "ANDA", "marketing_start_date": "20120927", "listing_expiration_date": "20261231"}